Mark Wunderlich
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
Papers in
- Hematology 73
- Acute Myeloid Leukemia Research 64
- Hematopoietic Stem Cell Transplantation 13
- Immunology 32
- Immune Cell Function and Interaction 16
- Co-authors
- James C. Mulloy (65 shared papers)Benjamin E. Mizukawa (22 shared papers)Christopher R. Vakoc (2 shared papers)Daniel Magoon (1 shared paper)Eric Wang (1 shared paper)Scott Lowe (1 shared paper)Scott C. Kogan (1 shared paper)Junwei Shi (1 shared paper)
- Journals
- Blood (30 papers)Leukemia (10 papers)Proceedings of the National Academy of Sciences (7 papers)Cancer Cell (7 papers)Journal of Clinical Investigation (7 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Mark Wunderlich
119 papers receiving 10.0k citations
Mark Wunderlich's Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 2.8k
- Cancer Research 2.4k
- Molecular Biology 7.4k
- Genetics 559
- Immunology 1.1k
Countries citing papers authored by Mark Wunderlich
This map shows the geographic impact of Mark Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wunderlich more than expected).
Fields of papers citing papers by Mark Wunderlich
This network shows the impact of papers produced by Mark Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wunderlich. The network helps show where Mark Wunderlich may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wunderlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1581 |
| 2 | R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling Hit paper breakdown → | 2017 | 939 |
| 3 | METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification Hit paper breakdown → | 2017 | 823 |
| 4 | Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia Hit paper breakdown → | 2019 | 730 |
| 5 | Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion Hit paper breakdown → | 2020 | 611 |
| 6 | 2010 | 338 | |
| 7 | 2008 | 279 | |
| 8 | The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia Hit paper breakdown → | 2022 | 257 |
| 9 | 2013 | 194 | |
| 10 | 2013 | 192 | |
| 11 | 2013 | 177 | |
| 12 | 2013 | 169 | |
| 13 | 2020 | 143 | |
| 14 | 2012 | 140 | |
| 15 | 2015 | 130 | |
| 16 | 2023 | 129 | |
| 17 | 2010 | 121 | |
| 18 | 1996 | 111 | |
| 19 | 2015 | 109 | |
| 20 | 2013 | 102 |
About Mark Wunderlich
Mark Wunderlich is a scholar working on Hematology, Immunology, Molecular Biology, Oncology and Genetics, having authored 125 papers that have together received 10.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (64 papers), Protein Degradation and Inhibitors (19 papers), Histone Deacetylase Inhibitors Research (16 papers), Immune Cell Function and Interaction (16 papers), Acute Lymphoblastic Leukemia research (13 papers), Hematopoietic Stem Cell Transplantation (13 papers), RNA modifications and cancer (11 papers) and RNA Interference and Gene Delivery (8 papers). The work is most often cited by research in Hematology (2.8k citations), Cancer Research (2.4k citations), Molecular Biology (7.4k citations), Genetics (559 citations) and Immunology (1.1k citations). Mark Wunderlich has collaborated with scholars based in United States, China and Japan. Frequent co-authors include James C. Mulloy, Benjamin E. Mizukawa, Christopher R. Vakoc, Daniel Magoon, Eric Wang, Scott Lowe, Scott C. Kogan, Junwei Shi, Katharina Blatt and Christopher Johns. Their work appears in journals such as Blood, Leukemia, Proceedings of the National Academy of Sciences, Cancer Cell and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.